Bruce Downey

CIK 1237257 · Chairman & CEO · last filed 2024-06-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$15.94M

Companies

Total Filings

Lifetime Open-Market Net

-$188.6K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

MNTA price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers

CARDINAL HEALTH INC — 20 joint filings, latest 2023-12-20

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CCCC	Director	489,542	$2.96	$1.45M	$0	6	2024-06-21
CAH	Director	53,929	$268.73	$14.49M	$0	16	2022-11-10
MOMENTA PHARMACEUTICALS INC (MNTA) Delisted	Director	0	—	—	-$188.6K	15	2020-10-01
MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted	Director	—	—	—	$0	2	2019-06-12
BARR PHARMACEUTICALS INC (BRL) Delisted	Chairman & CEO	—	—	—	$0	4	2008-11-24

Recent Filings · Page 4 of 5

46 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2013-11-07	CAH	Grant (A)	+2,612	$0	EDGAR
2013-06-13	MOMENTA PHARMACEUTICALS INC (MNTA) Delisted	Grant (A)	—	$0	EDGAR
2012-11-06	CAH	Grant (A)	+3,406	$0	EDGAR
2012-06-15	MOMENTA PHARMACEUTICALS INC (MNTA) Delisted	Grant (A)	—	$0	EDGAR
2011-11-03	CAH	Grant (A)	+3,195	$0	EDGAR
2011-06-15	MOMENTA PHARMACEUTICALS INC (MNTA) Delisted	Grant (A)	—	$0	EDGAR
2010-11-04	CAH	Grant (A)	+3,396	$0	EDGAR
2010-06-16	MOMENTA PHARMACEUTICALS INC (MNTA) Delisted	Grant (A)	—	$0	EDGAR
2009-11-05	CAH	Grant (A)	+4,119	$120.0K	EDGAR
2009-09-02	CAH	Grant (A)	+1,659	$0	EDGAR

Showing 31–40 of 46

Prev Page 4 of 5 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.